| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/HED.25695 |
| P698 | PubMed publication ID | 30788878 |
| P50 | author | James E Bates | Q57616444 |
| Robert J Amdur | Q90061216 | ||
| Roi Dagan | Q90564763 | ||
| P2093 | author name string | Christopher G Morris | |
| Alexandra N De Leo | |||
| P2860 | cites work | Human papillomavirus and survival of patients with oropharyngeal cancer. | Q27851567 |
| New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) | Q28131668 | ||
| Platinum-based chemotherapy plus cetuximab in head and neck cancer | Q33381094 | ||
| Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma | Q33668241 | ||
| Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. | Q34332841 | ||
| A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions | Q34723820 | ||
| Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy | Q36046884 | ||
| Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer | Q36332315 | ||
| Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment | Q37268974 | ||
| International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery | Q38011485 | ||
| Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study | Q38409259 | ||
| New Strategies in Stereotactic Radiotherapy for Oligometastases | Q38655501 | ||
| Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial. | Q38760078 | ||
| A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer | Q38790915 | ||
| Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer | Q39051290 | ||
| Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy". | Q39727939 | ||
| Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck | Q43164702 | ||
| Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors | Q50044559 | ||
| Surgical approach in the oligometastatic patient. | Q52581734 | ||
| Treatment of Sarcoma Lung Metastases with Stereotactic Body Radiotherapy. | Q55350018 | ||
| Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases | Q83412928 | ||
| Outcomes and toxicity for hypofractionated and single-fraction image-guided stereotactic radiosurgery for sarcomas metastasizing to the spine | Q87505189 | ||
| Oligometastatic status as predictor of survival in metastatic human papillomavirus-positive oropharyngeal carcinoma | Q88657851 | ||
| Stereotactic Ablative Body Radiotherapy for Primary Non-Small-Cell Lung Cancer: Achieving Local Control with a Lower Biologically Effective Dose | Q90440809 | ||
| P433 | issue | 7 | |
| P921 | main subject | head and neck squamous cell carcinoma | Q18348812 |
| P304 | page(s) | 2309-2314 | |
| P577 | publication date | 2019-02-20 | |
| P1433 | published in | Head & Neck | Q13703062 |
| P1476 | title | Oligometastatic squamous cell carcinoma of the head and neck treated with stereotactic body ablative radiotherapy: Single-institution outcomes | |
| P478 | volume | 41 |
| Q90027402 | Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer | cites work | P2860 |
Search more.